IFP Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

IFP Advisors’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4K	Hold	500	–	–	﹤0.01%	4154
2026 Q1	$1.7K	Hold	500	–	–	﹤0.01%	4019
2025 Q4	$1.43K	Hold	500	–	–	﹤0.01%	3953
2025 Q3	$1.32K	Hold	500	–	–	﹤0.01%	3842
2025 Q2	$1.13K	Hold	500	–	–	﹤0.01%	4183
2025 Q1	$1.07K	Hold	500	–	–	﹤0.01%	3320
2024 Q4	$1.21K	Hold	500	–	–	﹤0.01%	3241
2024 Q3	$1.22K	Hold	500	–	–	﹤0.01%	3046
2024 Q2	$1.28K	Hold	500	–	–	﹤0.01%	2932
2024 Q1	$1.46K	Sell	500 -1,000	-67%	-$2.8K	﹤0.01%	2773
2023 Q4	$3.46K	Sell	1,500 -235	-14%	-$502	﹤0.01%	2529
2023 Q3	$4.53K	Hold	1,735	–	–	﹤0.01%	2548
2023 Q2	$6.21K	Hold	1,735	–	–	﹤0.01%	2466
2023 Q1	$13.9K	Hold	1,735	–	–	﹤0.01%	2164
2022 Q4	$14K	Hold	1,735	–	–	﹤0.01%	3168
2022 Q3	$14K	Hold	1,735	–	–	﹤0.01%	3403
2022 Q2	$14K	Hold	1,735	–	–	﹤0.01%	3155
2022 Q1	$14K	Hold	1,735	–	–	﹤0.01%	3155
2021 Q4	$24K	Hold	1,735	–	–	﹤0.01%	1871
2021 Q3	$38K	Buy	1,735 +235	+16%	+$4K	﹤0.01%	1700
2021 Q2	$20K	Buy	+1,500	New	+$17.2K	﹤0.01%	1935

Other funds holding ORMP

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

SCM

Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFO

Pioneer Family Office North Miami Beach, Florida $194M AUM

IFP Advisors's ORMP Position: Q2 2026 in Review

IFP Advisors held its Oramed Pharmaceuticals (ORMP) position steady in Q2 2026 at 500 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4154.

IFP Advisors first reported a position in ORMP in Q2 2021 and has held it in 21 quarters since. The position peaked at $38K in Q3 2021. 14 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

IFP Advisors held 500 shares of Oramed Pharmaceuticals worth $2.4K as of Q2 2026.
IFP Advisors left its Oramed Pharmaceuticals share count unchanged in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4154 holding.
IFP Advisors first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
IFP Advisors's Oramed Pharmaceuticals position peaked at $38K in Q3 2021.
14 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.